Literature DB >> 20398107

Laser epithelial keratomileusis in 2010 - a review.

Michael O'Keefe1, Caitriona Kirwan.   

Abstract

Photorefractive keratectomy, laser epithelial keratomileusis (LASEK) and Epi-LASIK are all variants of a similar type refractive surgery involving laser on the surface of the cornea and differ mainly in management of the epithelium. Although laser in situ keratomileusis (LASIK) is currently the most popular form of refractive surgery, LASEK is the procedure of choice in some patients. We highlight potential complications of LASEK and how these may be managed. Following laser refractive surgery, corneal thickness is reduced, which has implications for intraocular pressure measurement and glaucoma screening and management. This is particularly important following surface laser procedures where no evidence of previous surgery may be visible. In the event that cataract surgery is required at a later date, correct calculation of the appropriate intraocular lens power can be difficult and it thus important that patients are given their preoperative keratometry readings and refraction. Compared with LASIK patients, those who undergo LASEK are considered to be at lower risk of corneal ectasia. Improved understanding of wound healing post LASEK and better postoperative pain management are ongoing challenges.

Entities:  

Mesh:

Year:  2010        PMID: 20398107     DOI: 10.1111/j.1442-9071.2010.02198.x

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN: 1442-6404            Impact factor:   4.207


  17 in total

1.  Not the Last Word: JoeCare: Free Health Insurance Coverage for All.

Authors:  Joseph Bernstein
Journal:  Clin Orthop Relat Res       Date:  2017-04-04       Impact factor: 4.176

2.  Higher order aberrations of the corneal surface after laser subepithelial keratomileusis.

Authors:  Hyun Ho Jung; Yong Sok Ji; Han Jin Oh; Kyung Chul Yoon
Journal:  Korean J Ophthalmol       Date:  2014-07-22

3.  Risk profiles of ectasia after keratorefractive surgery.

Authors:  Pushpanjali Giri; Dimitri T Azar
Journal:  Curr Opin Ophthalmol       Date:  2017-07       Impact factor: 3.761

4.  Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis).

Authors:  Edward E Manche; Weldon W Haw
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

Review 5.  Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.

Authors:  Shi-Ming Li; Siyan Zhan; Si-Yuan Li; Xiao-Xia Peng; Jing Hu; Hua Andrew Law; Ning-Li Wang
Journal:  Cochrane Database Syst Rev       Date:  2016-02-22

6.  Post photorefractive keratectomy (PRK) infectious keratitis; six-year experience of a tertiary eye hospital.

Authors:  Mohammad Soleimani; Mohammad Keykhaei; Seyed Ali Tabatabaei; Mansoor Shahriari; Hossein Farrokhpour; Bahareh Ramezani; Kasra Cheraqpour
Journal:  Eye (Lond)       Date:  2022-03-10       Impact factor: 3.775

7.  Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK.

Authors:  Xiao Jing Wang; Sze H Wong; Roshan Givergis; Emil W Chynn
Journal:  Clin Ophthalmol       Date:  2011-10-07

8.  Corneal biomechanics in iatrogenic ectasia and keratoconus: A review of the literature.

Authors:  Majid Moshirfar; Jason N Edmonds; Nicholas L Behunin; Steven M Christiansen
Journal:  Oman J Ophthalmol       Date:  2013-01

9.  Increased preference of surface ablation over laser in situ keratomileusis between 2008-2011 is correlated to risk of ecatasia.

Authors:  Elad Moisseiev; Tzahi Sela; Liza Minkev; David Varssano
Journal:  Clin Ophthalmol       Date:  2013-01-10

10.  Risk Factors in Post-LASIK Corneal Ectasia.

Authors:  Mehmet Gurkan Tatar; Feride Aylin Kantarci; Aydin Yildirim; Haşim Uslu; Hatice Nur Colak; Hasan Goker; Bulent Gurler
Journal:  J Ophthalmol       Date:  2014-06-03       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.